Navigation Links
University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing
Date:1/21/2009

ersity Medical Pharmaceuticals' growing line of skin and beauty care products are developed in conjunction with leading university dermatology departments and faculty members. Cornerstones of the company's skin care offerings include the AcneFree line of products that are consistently top sellers at retail accounts including Costco and Wal-Mart since introduction in 2003.

"As University Medical continues to expand its line of skin care solutions that really deliver results, the timing has never been better to introduce our effective and popularly-priced products to mass market retailers around the globe," said Tom Roche. "It is a real pleasure to be working with the nimble team of beauty care development professionals at University Medical who are quick to identify and productize the latest scientific breakthroughs to bring them to market on an expedited basis at very attractive price points."

Mr. Roche holds a Masters of Business Administration degree from Pepperdine University, a Bachelor of Arts in Business Administration from San Diego State University, and an Executive MBA certificate in Consumer Marketing Strategy from Columbia University, Graduate School of Business. Mr. Roche resides in the Newport Beach area with his family.

About University Medical Pharmaceuticals

Established in 1994, University Medical's corporate goal is to provide the mass market consumer with quality, affordable products that really work. The entire University Medical product line is developed in conjunction with leading university medical faculty and clinically tested in order to offer consumers an effective alternative to products offered on television or in high-end department stores. University Medical's product line features effective and budget-friendly solutions for range of life-cycle skin care issues including the AcneFree line for acne and rosacea, and the WrinkleFree array
'/>"/>

SOURCE University Medical Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. University of Iowa professor identifies new eating disorder
2. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. Tulane University to receive $14M for international HIV/AIDS program
5. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
6. Boston University School of Medicine researcher recipient of Memory Ride Grant
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
9. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
10. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
11. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... (PRWEB) May 24, 2015 For people ... and Chinese Enterokinase Industry, 2009-2019 Market Research Report would ... is an exhaustive study on the present market scenario ... insight into the growing Chinese market of this industry. ... the overall status of the manufacturers in this industry. ...
(Date:5/24/2015)... EnviroLeather™ by LDI, a leader ... a classic, rugged leather grain with enhanced stain ... including ink, to be easily removed. The collection ... corporate, healthcare, hospitality and education environments. , InkGard ... of developing products that are more sustainable, less ...
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading ... America, Inc. (MTA) has selected IFN as a fiber ... Enterprise Sales Manager, fiber route diversity and network redundancy ... provides MTA with the diverse fiber transport from their ... and voice carriers located at Henry Street in Indianapolis, ...
(Date:5/24/2015)... 2015 A report out just ... single best option for avoiding cardiovascular disease is exercise ... was the single most powerful predictor of death and ... diabetes and family history of premature death -- a ... and lung fitness. , The Importance of Cardiovascular Screening ...
(Date:5/23/2015)... 23, 2015 Dr. David Benvenuti, an experienced ... posted a new article to his website that ... Dr Benvenuti explained in the fascinating blog, he has ... their earlobes. , Known as “gauging,” the technique involves placing ... Dr. Benvenuti said will eventually stretch the holes out to ...
Breaking Medicine News(10 mins):Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2
... Health Care has been selected to be ... major state roadwork projects.(Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b )Preferred ... steered to Aurora Health Care,s Occupational Health during ... hours."Aurora was the preferred provider for the Marquette ...
... April 8 A nationwide poll conducted on ... surveyed believe it is important to "make sure ... to participate in procedures and practices to which ... company(TM), inc./WomanTrend on behalf of the Christian Medical ...
... evident symptoms of heartburn , , WEDNESDAY, April 8 (HealthDay ... you don,t have heartburn symptoms, too, a new study ... gastroesophageal reflux disease, or GERD. But some people have ... symptoms. , Doctors have suspected that if people with ...
... The Methuselah Foundation, a global nonprofit-organization dedicated ... co-sponsorship of My Bridge 4 Life(TM), a unique ... facing the challenges of a life threatening disease ... who have just been there.Through My Bridge 4 ...
... on April 24 ALEXANDRIA, Va., April 8 On ... CEO, joined an invitation-only meeting at the White House ... of the White House Office of Health Care Reform ... important meeting is an indicator of the commitment of ...
... Fla. and CHICAGO, April 8 The ... QGP ) following the conclusion of the HIMSS09* conference ... IBM ) to facilitate IBM,s Patient Centered Medical ... with a 21st Century process for electronic records integration, ...
Cached Medicine News:Health News:Aurora Chosen as Preferred Provider for Workers on 2 Major State Road Projects 2Health News:New Poll Shows Strong Support for Conscience Rights in Health Care 2Health News:Acid Reducers May Not Help All With Asthma 2Health News:Acid Reducers May Not Help All With Asthma 3Health News:The Methuselah Foundation Co-Sponsors My Bridge 4 Life and Tips 4 Life 2Health News:NHPCO President/CEO Meets with Nancy-Ann Min DeParle at White House 2Health News:Quantum and IBM Align to Drive Medical Home Solution 2Health News:Quantum and IBM Align to Drive Medical Home Solution 3Health News:Quantum and IBM Align to Drive Medical Home Solution 4Health News:Quantum and IBM Align to Drive Medical Home Solution 5Health News:Quantum and IBM Align to Drive Medical Home Solution 6
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
(Date:5/22/2015)... 22, 2015 According to a ... Product (Consumables, Instruments, Services), by Test Type (Indirect, Enzyme-based, ... Cytometry), by End Users - Global Forecast to 2020", ... expected to reach $736.85 Million by 2020 from $452.36 ... Browse 71 market data Tables and ...
(Date:5/22/2015)... 22, 2015 Today, Rhodes Pharmaceuticals L.P. announced ... stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder ... 2015. The announcement comes just ... the U.S. Food and Drug Administration (FDA). ... of methylphenidate capsule with an onset of effect ...
Breaking Medicine Technology:Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
... WIRE)--Apr 17, 2007 - ProNAi Therapeutics,Inc., a ... drugs based on DNA interference (DNAi), today,announced ... successfully demonstrated preclinical in vivo efficacy in,xenograft ... - including curative,events for difficult-to-treat Burkitt's Lymphoma., ...
... PALO ALTO, Calif., April 17, 2007 /PRNewswire-FirstCall/ ... results from a,Phase 2 clinical trial of ... carboplatin and paclitaxel in the,first-line treatment of ... highly statistically and clinically significant,improvement in both ...
Cached Medicine Technology:ProNAi Announces Preclinical Success for PNT2258 Therapeutic -,Curative Events in Xenograft Mice for Difficult-to-Treat,Non-Hodgkin's Lymphoma 2Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 2Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 3Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: